Hyperhomocysteinemia is associated with decreased apolipoprotein AI levels in normal healthy people

BACKGROUND: Hyperhomocysteinemia (HHcy) is an independent risk factor for various cardiovascular diseases. Animal studies have shown that homocysteine (Hcy) inhibits hepatic expression of apolipoprotein AI (apoAI). Our recent clinical study showed that increased plasma Hcy levels were associated wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ying, Liu, Jia, Jiang, Yuliang, Zhang, Heng, Leng, Song, Wang, Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4711068/
https://www.ncbi.nlm.nih.gov/pubmed/26758372
http://dx.doi.org/10.1186/s12872-016-0186-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4711068/
https://www.ncbi.nlm.nih.gov/pubmed/26758372
http://dx.doi.org/10.1186/s12872-016-0186-6

Ejemplares similares